NASDAQ:CBLI
Delisted

Cleveland BioLabs Stock Signals

$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 61 days ( 67.12 % )
Last Price $0.240 2.56 %
High/ Low $0.230 - $0.250 3.91%
Chg 7 Days -6.61 % $0.257 $0.240
Chg 30 Days 14.83 % $0.209 $0.240
Chg 12 mos -95.36 % $5.17 $0.240
Trend - 3 mos -60.12 % Width: 1,023.15 %
Trend - 12 mos -81.94 % Width: 175.13 %
Pred. range - 3 mos N/A - $0.132 -100.00 % - -44.91 %
Pred. range - 12 mos N/A - $0.222 -100.00 % - -7.68 %
Short MA avg 3 mos Sell 2022-05-23 - 5 days
Long MA avg 3 mos Buy 2022-04-27 - 23 days
Short/Long MA avg 3 mos Buy 2022-05-05 - 17 days
Short MA avg 12 mos Sell 2022-05-23 - 5 days
Long MA avg 12 mos Sell 2021-11-17 - 133 days
Short/Long MA avg 12 mos Sell 2021-11-30 - 125 days
Pivot Short Buy 2022-05-25 - 3 days
Bollinger Sell 0000-00-00 - N/A days
MACD Sell No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Cleveland BioLabs

Cleveland BioLabs Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate includes Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is used for the prevention of death from acute radiation syndrome, and is used as an oncology drug. The company is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics n... CBLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT